MDT: 10-Q financial filing

mdt-20260731 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2026 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) Building Two, Parkmore Business Park West Galway , Ireland (Address of principal executive offices) + 353 1 438-1700 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange 1.125% Senior Notes due 2027 MDT/27 New York Stock Exchange 0.375% Senior Notes due 2028 MDT/28 New York Stock Exchange 3.000% Senior Notes due 2028 MDT/28A New York Stock Exchange 3.650% Senior Notes due 2029 MDT/29 New York Stock Exchange 2.950% Senior Notes due 2030 MDT/30 New York Stock Exchange 1.625% Senior Notes due 2031 MDT/31 New York Stock Exchange 1.000% Senior Notes due 2031 MDT/31A New York Stock Exchange 3.125% Senior Notes due 2031 MDT/31B New York Stock Exchange 0.750% Senior Notes due 2032 MDT/32 New York Stock Exchange 3.375% Senior Notes due 2034 MDT/34 New York Stock Exchange 3.875% Senior Notes due 2036 MDT/36 New York Stock Exchange 2.250% Senior Notes due 2039 MDT/39A New York Stock Exchange 1.500% Senior Notes due 2039 MDT/39B New York Stock Exchange 1.375% Senior Notes due 2040 MDT/